Stoke Therapeutics (STOK) Property, Plant & Equipment (Net) (2018 - 2026)
Stoke Therapeutics (STOK) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 518.26 Mn |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.52 Bn | - | 3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40 Mn |
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 3.15 Mn |
| Dec 31, 2025 | 3.15 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 3.91 Mn |
| Dec 31, 2024 | 3.91 Mn |
| Sep 30, 2024 | 4.33 Mn |
| Sep 30, 2024 | 4.33 Mn |
| Jun 30, 2024 | 4.77 Mn |
| Jun 30, 2024 | 4.77 Mn |
| Mar 31, 2024 | 5.28 Mn |
| Mar 31, 2024 | 5.28 Mn |
| Dec 31, 2023 | 5.82 Mn |
| Dec 31, 2023 | 5.82 Mn |